Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04026776 · ClinicalTrials.gov registry record · Early Phase 1
Uric Acid, Klotho and Salt Sensitivity in Young Adults Born Preterm
A Early Phase 1 study of Blood Pressure Disorders and Salt; Excess, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT04026776 is a Early Phase 1 study of Blood Pressure Disorders and Salt; Excess that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 120 participants, below the 498-participant average among 7 other Blood Pressure Disorders trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04026776, a Early Phase 1 study of Blood Pressure Disorders and Salt; Excess, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to learn about how salt in the diet influences blood pressure in young adults who were born prematurely.
Conditions Studied
Interventions
- OTHER Dietary Intervention
- DRUG Allopurinol
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2020-09-02 |
| Est. Completion | 2026-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04026776
The ClinicalTrials.gov registry entry for NCT04026776 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 498-participant average among 7 other Blood Pressure Disorders trials with a reported enrollment target (76% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Blood Pressure Disorders appearing as the primary indexed condition, and to 2 interventions - of which Dietary Intervention is the first listed.
NCT04026776 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT04026776 about?
NCT04026776 is a clinical study titled "Uric Acid, Klotho and Salt Sensitivity in Young Adults Born Preterm". The purpose of this research is to learn about how salt in the diet influences blood pressure in young adults who were born prematurely.
What is the current status of trial NCT04026776?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 120 participants. The study started on 2020-09-02. Estimated completion is 2026-06.
What conditions does trial NCT04026776 study?
This clinical trial studies the following conditions: Blood Pressure Disorders, Salt; Excess.
What interventions are being tested in trial NCT04026776?
The interventions under investigation include: Dietary Intervention (OTHER), Allopurinol (DRUG).
Who is sponsoring clinical trial NCT04026776?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04026776 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety, Feasibility, and Efficacy of TSCS on Stabilizing Blood Pressure for Acute Inpatients With SCI
RECRUITING · NA
-
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
RECRUITING
-
Interprofessional Pharmacogenomics (IPGx) Registry and Repository
RECRUITING
-
ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury
RECRUITING · NA
-
Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy
COMPLETED · NA
-
Effect of Korean Red Ginseng Extract on Blood Flow in Healthy Adults
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.